Parkinson's Disease NFZ — 24 facilities in 23 cities

Parkinson's disease is a progressive neurodegenerative disorder presenting with resting tremor, muscle rigidity, slowness of movement, and balance impairment. The NFZ funds neurological diagnostics, treatment with levodopa, dopamine agonists, and MAO-B inhibitors, and in advanced cases, deep brain stimulation (DBS) and subcutaneous apomorphine delivery through drug programs.